Emergent informal use of doxycycline post- and pre-exposure prophylaxis among men who have sex with men and transgender and gender diverse people, the Netherlands, 2024

BACKGROUND Doxycycline post-exposure and pre-exposure prophylaxis (doxyPEP/PrEP) to prevent sexually transmitted infections (STIs) is not part of standard practice in the Netherlands but may be used informally (without prescription). AIM We assessed informal use and intention to use doxyPEP/PrEP amo...

Full description

Saved in:
Bibliographic Details
Main Author: Vita W Jongen
Format: Article
Language:English
Published: European Centre for Disease Prevention and Control 2025-07-01
Series:Eurosurveillance
Subjects:
Online Access:https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2025.30.26.2400707
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850083101804331008
author Vita W Jongen
author_facet Vita W Jongen
author_sort Vita W Jongen
collection DOAJ
description BACKGROUND Doxycycline post-exposure and pre-exposure prophylaxis (doxyPEP/PrEP) to prevent sexually transmitted infections (STIs) is not part of standard practice in the Netherlands but may be used informally (without prescription). AIM We assessed informal use and intention to use doxyPEP/PrEP among men who have sex with men (MSM) and transgender and gender diverse people in the Netherlands. METHODS Between 26 February and 6 May 2024, we conducted an online survey on informal doxyPEP/PrEP use in the preceding 6 months and intention to use. We assessed the determinants of recent informal use and high intention to use using risk ratio regression. RESULTS Of the 1,633 participating individuals (96.7% MSM) 246 (15%) reported doxyPEP/PrEP use in the preceding 6 months. Informal use was more common among participants who used HIV PrEP or were living with HIV, had ≥ 15 anonymous sexual partners, engaged in chemsex, wanted to protect themselves, got advice from others to use doxyPEP/PrEP and believed doxyPEP/PrEP is safe. High intention to use (n = 1,063 (65%) participants) was more common among participants using HIV PrEP or living with HIV, who wanted to have condomless sex, who wanted to protect others from STIs and who perceived doxyPEP/PrEP as effective and safe. CONCLUSION Although doxyPEP/PrEP is not formally recommended in the Netherlands, survey participants reported informal use and a high intention to use. These findings, combined with the global increase of antimicrobial resistance (AMR), stress the need for close monitoring and further research on the AMR effects of doxyPEP/PrEP use.
format Article
id doaj-art-4d261842e64c47ab9fb1be34ba141a05
institution DOAJ
issn 1560-7917
language English
publishDate 2025-07-01
publisher European Centre for Disease Prevention and Control
record_format Article
series Eurosurveillance
spelling doaj-art-4d261842e64c47ab9fb1be34ba141a052025-08-20T02:44:22ZengEuropean Centre for Disease Prevention and ControlEurosurveillance1560-79172025-07-01302610.2807/1560-7917.ES.2025.30.26.2400707http://instance.metastore.ingenta.com/content/eurosurveillance/30/26Emergent informal use of doxycycline post- and pre-exposure prophylaxis among men who have sex with men and transgender and gender diverse people, the Netherlands, 2024Vita W Jongen0https://orcid.org/0000-0001-9538-1501Stichting HIV monitoring, Amsterdam, the NetherlandsBACKGROUND Doxycycline post-exposure and pre-exposure prophylaxis (doxyPEP/PrEP) to prevent sexually transmitted infections (STIs) is not part of standard practice in the Netherlands but may be used informally (without prescription). AIM We assessed informal use and intention to use doxyPEP/PrEP among men who have sex with men (MSM) and transgender and gender diverse people in the Netherlands. METHODS Between 26 February and 6 May 2024, we conducted an online survey on informal doxyPEP/PrEP use in the preceding 6 months and intention to use. We assessed the determinants of recent informal use and high intention to use using risk ratio regression. RESULTS Of the 1,633 participating individuals (96.7% MSM) 246 (15%) reported doxyPEP/PrEP use in the preceding 6 months. Informal use was more common among participants who used HIV PrEP or were living with HIV, had ≥ 15 anonymous sexual partners, engaged in chemsex, wanted to protect themselves, got advice from others to use doxyPEP/PrEP and believed doxyPEP/PrEP is safe. High intention to use (n = 1,063 (65%) participants) was more common among participants using HIV PrEP or living with HIV, who wanted to have condomless sex, who wanted to protect others from STIs and who perceived doxyPEP/PrEP as effective and safe. CONCLUSION Although doxyPEP/PrEP is not formally recommended in the Netherlands, survey participants reported informal use and a high intention to use. These findings, combined with the global increase of antimicrobial resistance (AMR), stress the need for close monitoring and further research on the AMR effects of doxyPEP/PrEP use.https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2025.30.26.2400707post-exposure prophylaxisSTIantimicrobial-resistancepre-exposure prophylaxisdoxycyclineprevention
spellingShingle Vita W Jongen
Emergent informal use of doxycycline post- and pre-exposure prophylaxis among men who have sex with men and transgender and gender diverse people, the Netherlands, 2024
Eurosurveillance
post-exposure prophylaxis
STI
antimicrobial-resistance
pre-exposure prophylaxis
doxycycline
prevention
title Emergent informal use of doxycycline post- and pre-exposure prophylaxis among men who have sex with men and transgender and gender diverse people, the Netherlands, 2024
title_full Emergent informal use of doxycycline post- and pre-exposure prophylaxis among men who have sex with men and transgender and gender diverse people, the Netherlands, 2024
title_fullStr Emergent informal use of doxycycline post- and pre-exposure prophylaxis among men who have sex with men and transgender and gender diverse people, the Netherlands, 2024
title_full_unstemmed Emergent informal use of doxycycline post- and pre-exposure prophylaxis among men who have sex with men and transgender and gender diverse people, the Netherlands, 2024
title_short Emergent informal use of doxycycline post- and pre-exposure prophylaxis among men who have sex with men and transgender and gender diverse people, the Netherlands, 2024
title_sort emergent informal use of doxycycline post and pre exposure prophylaxis among men who have sex with men and transgender and gender diverse people the netherlands 2024
topic post-exposure prophylaxis
STI
antimicrobial-resistance
pre-exposure prophylaxis
doxycycline
prevention
url https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2025.30.26.2400707
work_keys_str_mv AT vitawjongen emergentinformaluseofdoxycyclinepostandpreexposureprophylaxisamongmenwhohavesexwithmenandtransgenderandgenderdiversepeoplethenetherlands2024